Clinical Trials Directory

Trials / Completed

CompletedNCT05775536

Detection of Acetylsalicylic Acid and Omega-3 Fatty Acids in Schirmers' Test Strips Using Mass Spectrometry

Detection of Acetylsalicylic Acid and Omega-3 Fatty Acids in Schirmers' Test Strips Using Mass Spectrometry and Correlations With Tear Film and Blood Flow Parameters in Healthy Adults: an Open-label Pilot Study

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
32 (actual)
Sponsor
Medical University of Vienna · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Accepted

Summary

Evaluation of tear fluid production using Schirmers' tests is a well-known and frequently used examination method in ophthalmology. Schirmers' test objectively indicates the tear fluid production over five minutes by insertion of a filter paper strip in the lower conjunctival fornix. Commonly, this method is used to quantify tear fluid production, but not tear fluid composition. The development of novel, very precise analytical methods opens up new possibilities in the use and application of Schirmers' test strips. A recently introduced analytical method is mass spectrometry. This method allows the detection and quantification of proteins, lipids, and metabolites in very low amounts of samples. Whether systemically ingested agents such as omega-3 fatty acids or acetylsalicylic acid can be detected in tear fluid using this method remains unclear. The aim of this study is to investigate the detectability of 2 different agents (acetylsalicylic acid and omega-3 fatty acids) in Schirmers' test strips from healthy subjects after intake for 1 week by use of untargeted mass spectrometry. Participating healthy subjects will receive either acetylsalicylic acid or omega-3 fatty acids.

Conditions

Interventions

TypeNameDescription
DRUGAspirin 500Mg TabDose: 1 tablet per day starting from visit 2 until visit 3, intake in the evening
DIETARY_SUPPLEMENTDr. Böhm® Omega 3 complex 870 mgDose: 2 tablets per day starting from visit 2 until visit 3, intake in the evening

Timeline

Start date
2021-01-21
Primary completion
2021-11-30
Completion
2021-11-30
First posted
2023-03-20
Last updated
2023-03-20

Locations

1 site across 1 country: Austria

Source: ClinicalTrials.gov record NCT05775536. Inclusion in this directory is not an endorsement.